Homeopathic Remedies in Psychiatric Disorders: A Meta-analysis of Randomized Controlled Trials.
Journal
Journal of clinical psychopharmacology
ISSN: 1533-712X
Titre abrégé: J Clin Psychopharmacol
Pays: United States
ID NLM: 8109496
Informations de publication
Date de publication:
Historique:
entrez:
26
4
2020
pubmed:
26
4
2020
medline:
14
1
2021
Statut:
ppublish
Résumé
Homeopathy is a complementary and alternative medicine. Conclusive evidence on the plausibility, efficacy, and safety of these treatments is not currently available. Nonetheless, homeopathic remedies (HRs) are widespread throughout the world and especially in mental disorders. The aim is to assess the efficacy of HRs in the treatment of mental disorders. We performed a Medline/Embase search for studies written in English and published from any date to October 23, 2018. All randomized controlled trials enrolling patients with any psychiatric disorder and comparing HR with placebo, no treatment, or other psychotropic drugs were included. A total of 212 studies were screened, 9 met all selection criteria and reported data on major depressive disorder (MDD) (n = 4), generalized anxiety disorder (n = 1), attention-deficit/hyperactivity disorder (n = 2), and premenstrual syndrome/dysphoric disorder (n = 2). Eight of 9 randomized controlled trials showed high risk of bias. Homeopathy showed greater efficacy in MDD compared with fluoxetine, and in premenstrual syndrome/dysphoric disorder compared with placebo, whereas no difference emerged between homeopathy and placebo in MDD and attention deficit/hyperactivity disorder. Available data on homeopathy in psychiatric disorders are insufficient to support their use in clinical practice.
Sections du résumé
PURPOSE/BACKGROUND
OBJECTIVE
Homeopathy is a complementary and alternative medicine. Conclusive evidence on the plausibility, efficacy, and safety of these treatments is not currently available. Nonetheless, homeopathic remedies (HRs) are widespread throughout the world and especially in mental disorders. The aim is to assess the efficacy of HRs in the treatment of mental disorders.
METHODS/PROCEDURES
METHODS
We performed a Medline/Embase search for studies written in English and published from any date to October 23, 2018. All randomized controlled trials enrolling patients with any psychiatric disorder and comparing HR with placebo, no treatment, or other psychotropic drugs were included.
FINDINGS/RESULTS
RESULTS
A total of 212 studies were screened, 9 met all selection criteria and reported data on major depressive disorder (MDD) (n = 4), generalized anxiety disorder (n = 1), attention-deficit/hyperactivity disorder (n = 2), and premenstrual syndrome/dysphoric disorder (n = 2). Eight of 9 randomized controlled trials showed high risk of bias. Homeopathy showed greater efficacy in MDD compared with fluoxetine, and in premenstrual syndrome/dysphoric disorder compared with placebo, whereas no difference emerged between homeopathy and placebo in MDD and attention deficit/hyperactivity disorder.
IMPLICATIONS/CONCLUSIONS
CONCLUSIONS
Available data on homeopathy in psychiatric disorders are insufficient to support their use in clinical practice.
Identifiants
pubmed: 32332462
doi: 10.1097/JCP.0000000000001196
pii: 00004714-202005000-00008
doi:
Substances chimiques
Psychotropic Drugs
0
Types de publication
Journal Article
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
269-275Références
Relton C, Cooper K, Viksveen P, et al. Prevalence of homeopathy use by the general population worldwide: a systematic review. Homeopathy. 2017;106:69–78.
Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Ann Intern Med. 2003;138:393–399.
Grimes DR. Proposed mechanisms for homeopathy are physically impossible. Focus Altern Complement Ther. 2012;17:149–155.
Maddox J, Randi J, Stewart WW. “High-dilution” experiments a delusion. Nature. 1988;334:287–290.
Upadhyay RP, Nayak C. Homeopathy emerging as nanomedicine. Int J High Dilution Res. 2011;10:299–310.
Bell IR, Schwartz GE. Adaptive network nanomedicine an integrated model for homeopathic medicine. Front Biosci (Schol Ed). 2013;5:685–708.
Demangeat JL. Gas nanobubbles and aqueous nanostructures: the crucial role of dynamization. Homeopathy. 2015;104:101–115.
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA. 1998;280:1569–1575.
Dossett M, Yeh G. Homeopathy use in the United States and implications for public health: a review. Homeopathy. 2018;107:3–9.
Dossett ML, Davis RB, Kaptchuk TJ, et al. Homeopathy use by US adults: results of a national survey. Am J Public Health. 2016;106:743–745.
Kessler RC, Soukup J, Davis RB, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158:289–294.
Ogbogu U, Necyk C. Community Pharmacists' Views and Practices Regarding Natural Health Products Sold in Community Pharmacies. PLoS One. 2016;11:e0163450.
Van Wassenhoven M, Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy. 2004;93:3–11.
Davidson JR, Morrison RM, Shore J, et al. Homeopathic treatment of depression and anxiety. Altern Ther Health Med. 1997;3:46–49.
Villet S, Vacher V, Colas A, et al. Open-label observational study of the homeopathic medicine Passiflora compose for anxiety and sleep disorders. Homeopathy. 2016;105:84–91.
Coppola L, Montanaro F. Effect of a homeopathic-complex medicine on state and trait anxiety and sleep disorders: a retrospective observational study. Homeopathy. 2013;102:254–261.
Oberai P, Balachandran I, Janardhanan Nair K, et al. Homoeopathic management in depressive episodes: a prospective, unicentric, non-comparative, open-label observational study. Indian J Res Homoeopath. 2013;7:116.
Grimaldi-Bensouda L, Abenhaim L, Massol J, et al. Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort study. BMC Complement Altern Med. 2016;16:125.
Mathie R, Ulbrich-Zürni S, Viksveen P, et al. Systematic review and meta-analysis of randomised, other-than-placebo controlled, trials of individualised homeopathic treatment. Homeopathy. 2018;107:229–243.
Mathie RT, Ramparsad N, Legg LA, et al. Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev. 2017;6:63.
Shang A, Huwiler-Müntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005;366:726–732.
Mathie RT, Lloyd SM, Legg LA, et al. Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev. 2014;3:142.
Thurneysen A. Open letter to the editor of the lancet from the Swiss Association of Homoeopathic Physicians (SVHA). Homeopathy. 2006;95:61–62.
Pilkington K, Kirkwood G, Rampes H, et al. Homeopathy for anxiety and anxiety disorders: a systematic review of the research. Homeopathy. 2006;95:151–162.
Pilkington K, Kirkwood G, Rampes H, et al. Homeopathy for depression: a systematic review of the research evidence. Homeopathy. 2005;94:153–163.
Coulter MK, Dean ME. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder. Cochrane Database Syst Rev. 2007;CD005648.
Davidson JR, Crawford C, Ives JA, et al. Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies. J Clin Psychiatry. 2011;72:795–805.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Higgins JPT, Altman DG, Sterne J. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons Ltd; 2011.
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. www.handbook.cochrane.org. Published 2011. Accessed July 18, 2019.
Adler UC, Paiva NM, Cesar AT, et al. Homeopathic individualized Q-potencies versus fluoxetine for moderate to severe depression: double-blind, randomized non-inferiority trial. Evid Based Complement Alternat Med. 2011;2011:520182.
Adler UC, Krüger S, Teut M, et al. Homeopathy for depression: a randomized, partially double-blind, placebo-controlled, four-armed study (DEP-HOM). PLoS One. 2013;8:e74537.
Macías-Cortés Edel C, Llanes-González L, Aguilar-Faisal L, et al. Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP Study): a randomized, double-dummy, double-blind, placebo-controlled trial. PLoS One. 2015;10:e0118440.
Viksveen P, Relton C, Nicholl J. Depressed patients treated by homeopaths: a randomised controlled trial using the “cohort multiple randomised controlled trial” (cmRCT) design. Trials. 2017;18:299.
Bonne O, Shemer Y, Gorali Y, et al. A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. J Clin Psychiatry. 2003;64:282–287.
Jacobs J, Williams AL, Girard C, et al. Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized-controlled trial. J Altern Complement Med. 2005;11:799–806.
Frei H, Everts R, von Ammon K, et al. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr. 2005;164:758–767.
Yakir M, Kreitler S, Brzezinski A, et al. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br Homeopath J. 2001;90:148–153.
Klein-Laansma CT, Jong M, von Hagens C, et al. Semi-individualized homeopathy add-on versus usual care only for premenstrual disorders: a randomized, controlled feasibility study. J Altern Complement Med. 2018;24:684–693.
Lind J. A Treatise of the Scurvy in Three Parts. Containing an Inquiry into the Nature, Causes and Cure of That Disease, Together With a Critical and Chronological View of What Has Been Published on the Subject. London, UK: A. Millar; 1753.
Cochrane AL. Sickness in Salonica: my first, worst, and most successful clinical trial. BMJ. 1984;289:1726–1727.
Mintel Group Ltd. Homeopathic and Herbal Remedies — US — November 2016. Published 2016. Available at: https://store.mintel.com/homeopathic-and-herbal-remedies-us-november-2016. Accessed May 19, 2019.
Nahin RL, Barnes PM, Stussman BJ, et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;1–14.
European Coalition on Homeopathic & Anthroposophic Medicinal Products. EU Market for Homeopathic and Anthroposophic Medicines Grows by Over 6% a Year. Published 2015. Available at: https://www.echamp.eu/news-and-events/news/eu-market-for-homeopathic-and-anthroposophic-medicines-grows-by-over-6-a-year. Accessed May 19, 2019.
Thomas ET, Clark J, Glasziou P. Publication and outcome reporting of homeopathy trials registered in ClinicalTrials.gov. Focus Altern Complement Ther. 2016;21:127–133.
Jonas WB, Anderson RL, Crawford CC, et al. A systematic review of the quality of homeopathic clinical trials. BMC Complement Altern Med. 2001;1:12.
Pinto-Meza A, Usall J, Serrano-Blanco A, et al. Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? J Affect Disord. 2006;93:53–60.
Schneider LS, Small GW, Hamilton SH, et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psychiatry. 1997;5:97–106.
Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause. 2005;12:18–26.
Beasley CM, Potvin JH. Fluoxetine: activating and sedating effects. Int Clin Psychopharmacol. 1993;8:271–275.
Gram L. Fluoxetine. N Engl J Med. 1994;331:1354–1361.
Zienowicz M, Wisłowska-Stanek A, Lehner M, et al. Fluoxetine-induced anxiety and nervousness. Pharmacol Rep. 2006;58:115–119.
Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;CD003974.
Charlesworth JEG, Petkovic G, Kelley JM, et al. Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. J Evid Based Med. 2017;10:97–107.